In-hospital changes of echocardiographic parameters and their relationship with the procollagen I C-terminal propeptide in patients with myocardial infarction and preserved left ventricle systolic function

Aim. To study the changes of echocardiographic parameters and their relationship with the procollagen I C-terminal propeptide (PICP) during hospitalization of patients with ST-segment elevation myocardial infarction (STEMI) and preserved left ventricular (LV) systolic function.

Material and methods. A total of 120 (100%) patients hospitalized with STEMI were examined. Upon admission, all patients underwent standard examinations to verify myocardial infarction (MI), including coronary angiography and, if necessary, coronary stent implantation. The mean values of LV ejection fraction (LVEF) were 40-49% in 3 patients (2,5%), <40% — in 31 patients (26%), LVEF was. We also analyzed patients with LVEF ≥50%, n=86 (71,6%); mean age was 57,8 years. During the hospitalization, all patients received standard therapy; on the 1st and 12th day of MI, the PICP levels in venous blood serum was determined by enzyme-linked immunosorbent assay. In order to compare PICP values, a control group of healthy volunteers n=20 (100%) was formed, which were comparable by gender and age. In this group, the concentration of PICP was 179,2 [163.5; 194.9] ng/ml.

Results. By the 12th day, a significant decrease in the following parameters of the transmitral flow was revealed: DT (p=0,049), dE (0,012), Em (0,029), Em/ Am (p=0,000), Em/PICP (p=0,001). This indicates diastolic function deterioration. At the same time, by the end of hospitalization, systolic function deterioration was recorded in 15,1% of cases. Initially, a higher PICP on the 1st day relative to the control group tended to decrease the concentration by the 12th day, but the differences did not reach statistical significance (p=0,466). Correlation analysis showed a relationship between PICP and echocardiography (Tei index, p=0,026, and mitral annulus velocity, p=0,049).

Conclusion. At the hospital stage of treatment of patients with STEMI and preserved LVEF, a negative changes of echocardiography parameters characterizing diastolic dysfunction was revealed. Positive correlation was established between the concentration of PICP with mitral annulus velocity and the Tei index, indicating an association between the myocardial fibrosis and diastolic dysfunction.

1. Iskakov EB. Epidemiology of cardiovascular diseases. Medicine and Ecology. 2017;2(83):19-28. (In Russ.)

2. Kontsevaya AV, Drapkina OM, Balanova YuA, et al. Economic damage to cardiovascular diseases in the Russian Federation in 2016. Rational Pharmacotherapy in Cardiology. 2018;14(2):156-66. (In Russ.) doi:10.20996/1819-6446-201814-2-156-166.

3. Diuzheva EV. The prevalence of risk factors for cardiovascular disease among the population of different countries. Modern problems of science and education. 2017;5. (In Russ.) URL: http://www.science-education.ru/ru/article/view?id=26898

4. Bunova SS, Usacheva EV, Zamakhina OV. The dynamics of myocardial infarction incidence in the regions of the Russian Federation for the 11-year period (2002-2012). Social aspects of public health. 2015;1:3. (In Russ)

5. Samorodskaya IV, Barbarash ОL, Kashtalap VV, Starinskaya МА. Mortality from myocardial infarction in Russia in the years 2006 and 2015. Russ J Cardiol. 2017;(11):22-6. (In Russ.) doi:10.15829/15604071-2017-11-22-26.

6. Khera S, Kolte D, Gupta T, et al. Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States. J Am Coll Cardiol. 2015;66(18):1961-72. doi:10.1016/j.jacc.2015.08.865.

7. Shilov SN, Teplyakov AT, Yakovleva IV, et al. Clinical and pathogenic relationship between chronic heart failure, type 2 diabetes mellitus and osteoporosis. Complex Issues of Cardiovascular Diseases. 2018;7(1):6-13. (In Russ.) doi:10.17802/2306-1278-2018-7-1-6-13.

8. Carrick D, Haig C, Rauhalammi SM, et al. Pathophysiology of myocardial remodeling in survivors of ST-elevation myocardial infarction revealed by native T1 mapping: inflammation, remote myocardium and prognostic significance. Journal of Cardiovascular Magnetic Resonance. 2015;17:52. doi:10.1186/1532-429X-17-S1-Q52.

9. von Lueder TG, Wang BH, Kompa AR. Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy. Circulation: Heart Failure. 2015;8:71-8. doi:10.1161/CIRCHEARTFAILURE.114.001785.

10. Karetnikova VN, Kashtalap VV, Kosareva SN, Barbarash OL. Myocardial fibrosis: current aspects of the problem. Terapevticheskij arxiv. 2017;89(1):88-93. (In Russ.) doi:10.17116/terarkh201789188-93.

11. Atkov OYu. Ultrasound examination of the heart and blood vessels. Edited by Atkov O. Yu. 2nd edition expanded and expanded. M.: Eksmo, 2015 p.456. (In Russ.) ISBN 978-5-699-55204-7.

12. Besli F, Basar C, Ekinozu I, et al. Relationship Between Tei Index and PEP-Derived Myocardial Performance Index in Sinus Rhythm. Medicine (Baltimore). 2015;94(29):1112. doi:10.1097/MD.0000000000001112.

13. Kaplan S, Ozturk M, Kırış G, Kaplan ST. Evaluation of the relationship between epicardial adipose tissue and myocardial performance (Tei) index. Int. J. Clin. Exp. Med. 2014;15, 7(6):1598-602.

14. Goroshi M, Chand D. Myocardial Performance Index (Tei Index): A simple tool to identify cardiac dysfunction in patients with diabetes mellitus. Indian Heart Journal;68(2016):83-7. doi:10.1016/j.ihj.2015.06.022.

15. Govorin AV, Ratsina EV, Fetisova NV, Sokolova NA. Blood level of collagen biomarkers and sulfated glycosaminoglicans in acute transmural myocardial infarction. Russian Journal of Cardiology. 2016;(3):75-9. (In Russ.) doi:10.15829/1560-40712016-3-75-79.